$Abivax S.A.(ABVX)$ May God bless and make this stock of mine decline. If it can't drop now, please give the main force a chance to let me escape, and let it drop to 50 to 60. And in the future, when I get better, I will surely repay society. Please let me go.
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.